SEC Form 4/A · accession 0001615774-16-005165
ANAVEX LIFE SCIENCES CORP. · AVXL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Elliot Favus
Director
Period of report
Sep 30, 2015
Accepted (ET)
May 2, 2016 · 6:02 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001314052
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1,F2 | $5.64 | Sep 30, 2015 | A | 1,500 | A | Dec 31, 2015 | Sep 30, 2025 | Common Stock | 1,500 | 1,500 | D |
| Stock Option (Right to Buy)F1,F2 | $5.57 | Dec 31, 2015 | A | 1,500 | A | Dec 31, 2015 | Dec 31, 2025 | Common Stock | 1,500 | 1,500 | D |
Explanation of responses
- F1This Form 4 is being amended to reflect revised exercise prices of the options granted to Mr. Favus and the reflect that 3,000 options had been issued rather than 4,500 options as previously reported.
- F2Pursuant to the Company's ongoing obligation to grant to Mr. Favus options to purchase 1,500 shares at the end of each fiscal quarter as compensation for his service on Board Committees, an aggregate of 3,000 options were granted to Mr. Favus for the fiscal quarters ended September 30, 2015 and December 31, 2015.